Cross comparison of rapid mycoplasma detection platforms

Bill Lawrence1, Houman Bashiri, Houman Dehghani

  • 1Biosafety Development Laboratory, Cellular Resources, Amgen, 1201 Amgen Court West, Seattle, WA 98119, USA. bill.lawrence@amgen.com

Summary

Rapid detection of mycoplasma contamination in cell cultures is crucial for biopharmaceutical production. Nucleic acid-based methods proved superior to culture-based assays for identifying mycoplasma infections.